# TherapeuticsMD Inc. (TXMD)

Source: https://www.quantisnow.com/company/TXMD
Generated: 2026-11-13T23:09:19.620Z

- Ticker: TXMD
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0000025743
- Website: therapeuticsmd.com

## About

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

## Latest TXMD news and filings

- 2026-11-13 21:07 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-therapeuticsmd-inc-6790586)
- 2026-11-13 21:05 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-6790512)
- 2026-11-13 21:05 UTC [Earnings] [TherapeuticsMD Announces Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/therapeuticsmd-announces-third-quarter-2026-financial-results-6790455)
- 2026-08-11 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-therapeuticsmd-inc-6675718)
- 2026-08-11 20:00 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-6675581)
- 2026-08-11 20:00 UTC [TherapeuticsMD Announces Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/therapeuticsmd-announces-second-quarter-2026-financial-results-6675560)
- 2026-05-12 20:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-therapeuticsmd-inc-6548204)
- 2026-05-12 20:10 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-6548068)
- 2026-05-12 20:05 UTC [TherapeuticsMD Announces First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/therapeuticsmd-announces-first-quarter-2026-financial-results-6547859)
- 2026-04-01 01:53 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-therapeuticsmd-inc-6480447)
- 2026-04-01 01:48 UTC [SEC Form NT 10-K filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-therapeuticsmd-inc-6480432)
- 2026-03-30 21:56 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-6477099)
- 2026-03-30 21:43 UTC [SEC Form 10-K] [SEC Form 10-K filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-therapeuticsmd-inc-6477069)
- 2026-03-30 20:05 UTC [TherapeuticsMD Announces Full Year 2025 Financial Results](https://www.quantisnow.com/insight/therapeuticsmd-announces-full-year-2025-financial-results-6476523)
- 2025-12-29 21:23 UTC [Insider Buy] [Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)](https://www.quantisnow.com/insight/director-thompson-tommy-g-bought-14031-worth-of-shares-8400-6328662)
- 2025-12-16 21:01 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-submission-of-matters-to-6317865)
- 2025-11-13 01:54 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-6275826)
- 2025-11-12 22:27 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-therapeuticsmd-inc-6275502)
- 2025-11-12 21:05 UTC [TherapeuticsMD Announces Third Quarter 2025 Financial Results](https://www.quantisnow.com/insight/therapeuticsmd-announces-third-quarter-2025-financial-results-6274224)
- 2025-11-05 21:18 UTC [SEC Form 4] [SEC Form 4 filed by Director Thompson Tommy G](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-thompson-tommy-g-6262672)
- 2025-11-05 21:17 UTC [SEC Form 4] [SEC Form 4 filed by Director Naughton Gail K](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-naughton-gail-k-6262657)
- 2025-11-05 21:17 UTC [SEC Form 4] [SEC Form 4 filed by Director Collins Cooper C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-collins-cooper-c-6262607)
- 2025-11-05 21:16 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Walker Marlan D](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-walker-marlan-6262603)
- 2025-11-03 21:03 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-therapeuticsmd-inc-6256368)
- 2025-11-03 21:02 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-therapeuticsmd-inc-6256356)
- 2025-10-24 20:06 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-therapeuticsmd-inc-6244550)
- 2025-08-12 20:34 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-therapeuticsmd-inc-6161074)
- 2025-08-12 20:16 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-6160782)
- 2025-08-12 20:05 UTC [TherapeuticsMD Announces Second Quarter 2025 Financial Results](https://www.quantisnow.com/insight/therapeuticsmd-announces-second-quarter-2025-financial-results-6160488)
- 2025-05-13 20:37 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-therapeuticsmd-inc-6036397)
- 2025-05-13 20:15 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-6036068)
- 2025-04-30 21:00 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-therapeuticsmd-inc-6011181)
- 2025-04-15 11:59 UTC [Insider Buy] [Director Thompson Tommy G bought $326 worth of shares (325 units at $1.00), increasing direct ownership by 2% to 14,779 units (SEC Form 4)](https://www.quantisnow.com/insight/director-thompson-tommy-g-bought-326-worth-of-shares-325-5987715)
- 2025-04-15 11:59 UTC [Insider Buy] [Chief Executive Officer Walker Marlan D bought $489 worth of shares (490 units at $1.00), increasing direct ownership by 0.67% to 73,639 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-walker-marlan-d-bought-489-worth-of-5987714)
- 2025-04-10 20:29 UTC [Insider Buy] [Chief Executive Officer Walker Marlan D bought $1,994 worth of shares (2,303 units at $0.87), increasing direct ownership by 3% to 73,149 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-walker-marlan-d-bought-1994-worth-of-5984476)
- 2025-04-09 10:30 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-other-events-5982079)
- 2025-03-27 20:50 UTC [SEC Form 10-K] [SEC Form 10-K filed by TherapeuticsMD Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-therapeuticsmd-inc-5963530)
- 2025-03-27 20:30 UTC [SEC Form 8-K] [TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/therapeuticsmd-inc-filed-sec-form-8-k-results-of-operations-and-5963370)
- 2025-03-27 20:05 UTC [TherapeuticsMD Announces Full Year 2024 Financial Results](https://www.quantisnow.com/insight/therapeuticsmd-announces-full-year-2024-financial-results-5962951)
- 2025-02-21 02:08 UTC [SEC Form 4] [Director Collins Cooper C. converted options into 8,500 shares, increasing direct ownership by 16% to 60,516 units (SEC Form 4)](https://www.quantisnow.com/insight/director-collins-cooper-c-converted-options-into-8500-shares-increasing-5901831)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TXMD
- Earnings history: https://www.quantisnow.com/earnings/TXMD
- Dividend history: https://www.quantisnow.com/dividends/TXMD
- Insider transactions: https://www.quantisnow.com/insiders/TXMD
- Options chain: https://www.quantisnow.com/options/TXMD
- SEC 8-K filings only: https://www.quantisnow.com/company/TXMD/8-k
- RSS and alerts for TXMD: https://www.quantisnow.com/docs/rss-feeds.md